Aerosol tribocharging and its relation to the deposition of Oxis™ Turbuhaler® in the electrical next generation impactor

Journal of Pharmaceutical Sciences

Volumn 100, Issue 12, 2011, Pages 5270-5280

  Hoe, Susan ^a   Young, Paul M ^a   Traini, Daniela ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aerosol; Dry powder inhaler; Eformoterol; ENGI; Lactose; Materials science; Particle size; Pulmonary drug delivery; Static charge; Turbuhaler

Indexed keywords

FORMOTEROL; LACTOSE;

AEROSOL; ARTICLE; DRUG FORMULATION; DRY POWDER; FLOW RATE; FRAGMENTATION REACTION; PARTICLE SIZE; POWDER INHALER;

EID: 80054931751     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22721     Document Type: Article

References (15)

1. Frijlink HW, De Boer AH. 2004. Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv 1(1):67-86.
2. Wetterlin K. 1988. Turbuhaler-A new powder inhaler for administration of drugs to the airways. Pharm Res 5(8):506-508.
3. Weuthen T, Roeder S, Brand P, Mullinger B, Scheuch G. 2002. In vitro testing of two formoterol dry powder inhalers at different flow rates. J Aerosol Med 15(3):297-303.
4. Balachandran W, Machowski W, Gaura E, Hudson C. 1997. Control of drug aerosol in human airways using electrostatic forces. J Electrostat 40-41:579-584.
5. Melandri C, Tarroni G, Prodi V, De Zaiacomo T, Formignani M, Lombardi CC. 1983. Deposition of charged particles in the human airways. J Aerosol Sci 14(5):657-669.
6. Prodi V, Mularoni A. 1985. Electrostatic lung deposition experiments with humans and animals. Ann Occup Hyg 29(2):229-240.
7. Elajnaf A, Carter P, Rowley G. 2006. Electrostatic characterisation of inhaled powders: Effect of contact surface and relative humidity. Eur J Pharm Sci 29(5):375-384.
8. Hoe S, Traini D, Chan H-K, Young PM. 2010. The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems. Pharm Res 27(7):1325-1336.
9. Telko MJ, Kujanpaa J, Hickey AJ. 2007. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI). Int J Pharm 336(2):352-360.
10. Young PM, Sung A, Traini D, Kwok P, Chiou H, Chan HK. 2007. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Pharm Res 24(5):963-970.
11. British Pharmacopoeia. 2010. Section 2.9.18-Appendix XII C. Consistency of formulated preparations for inhalation.
12. United States Pharmacopeia. 2008. Chapter <601>. United States Pharmacopeial Convention.
13. Hoe S, Traini D, Chan H-K, Young P. 2009. The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers. Pharm Res 26(12):2639-2646.
14. Hoe S, Young PM, Chan HK, Traini D. 2009. Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers. Pharm Res 26(2):431-437.
15. Hoe S, Traini D, Chan HK, Young PM. 2009. Measuring charge and mass distributions in dry powder inhalers using the electrical next generation impactor (eNGI). Eur J Pharm Sci 38(2):88-94.